AXON Connected, a company that commercializes technology, said it has had a preliminary closing on $2.1 million in its second round of funding. The capital came entirely from existing investors. The company plans to invest the new funds in its subsidiaries -- AxonDx, a medical diagnostic company launching its first products related to early stage cancer detection, therapeutic monitoring, and point of care diagnostics, and AXON AI, a company developing products for its swarm-based artificial intelligence. Kent Murphy, the president and CEO of AXON Connected, said AXON Connected is grateful for the continued confidence and support of its early investors, and that advanced discussions with outside investors for more capital are already underway.

Click here for press release.